Activist Investing LLC 4
4 · TITAN PHARMACEUTICALS INC · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Lazar David E.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001
2023-01-24$0.97/sh+37,500$36,221→ 3,368,902 total - Purchase
Common Stock, par value $0.001
2023-01-25$1.00/sh+20,000$20,066→ 3,388,902 total
Holdings
- 359,066(indirect: By LLC)
Common Stock, par value $0.001
Footnotes (5)
- [F1]Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.9591 to $0.98. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
- [F2]This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
- [F3]Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
- [F4]Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.97 to $1.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
- [F5]Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.